Skip to main navigation Skip to search Skip to main content

Aqueous colloidal nanoplatelets for imaging and improved ALA-based photodynamic therapy of prostate cancer cells

  • Kubra Onbasli
  • , Gozde Demirci
  • , Furkan Isik
  • , Emek Goksu Durmusoglu
  • , Hilmi Volkan Demir*
  • , Havva Yagci Acar*
  • *Corresponding author for this work
  • Koc University
  • Bilkent University
  • Nanyang Technological University

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Fluorescent, CdSe/CdS core/crown heterostructured nanoplatelets (NPLs) were transferred to the water via a simple, single-step ligand exchange using 2-mercaptopropionic acid in a simple extraction process. These stable, aqueous NPLs were loaded with a modal drug, 5-aminolevulinic acid (ALA). ALA-loaded NPLs emerged as a new class of theranostic nanoparticles for image-guided enhanced photodynamic therapy of both androgen-dependent and -independent human prostate cancer cells.

Original languageEnglish
Pages (from-to)10512-10515
Number of pages4
JournalChemical Communications
Volume59
Issue number70
DOIs
Publication statusPublished - 21 Jul 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 The Royal Society of Chemistry.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Aqueous colloidal nanoplatelets for imaging and improved ALA-based photodynamic therapy of prostate cancer cells'. Together they form a unique fingerprint.

Cite this